DGX Quest Diagnostics Inc

Price (delayed)

$132.91

Market cap

$14.71B

P/E Ratio

17.51

Dividend/share

$2.84

EPS

$7.59

Enterprise value

$19.4B

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
Quest Diagnostics's quick ratio has increased by 18% QoQ and by 7% YoY
Quest Diagnostics's equity has increased by 7% YoY
DGX's price to earnings (P/E) is 17% higher than its 5-year quarterly average of 14.8 but 10% lower than its last 4 quarters average of 19.1
The net income has grown by 12% from the previous quarter but it has contracted by 10% YoY
Quest Diagnostics's debt has increased by 16% YoY and by 9% QoQ
The gross profit has decreased by 11% YoY

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
110.71M
Market cap
$14.71B
Enterprise value
$19.4B
Valuations
Price to book (P/B)
2.37
Price to sales (P/S)
1.62
EV/EBIT
15.47
EV/EBITDA
11.46
EV/Sales
2.1
Earnings
Revenue
$9.25B
EBIT
$1.25B
EBITDA
$1.69B
Free cash flow
$864M
Per share
EPS
$7.59
Free cash flow per share
$7.68
Book value per share
$56.09
Revenue per share
$82.29
TBVPS
$45.56
Balance sheet
Total assets
$14.02B
Total liabilities
$7.68B
Debt
$5.37B
Equity
$6.31B
Working capital
$557M
Liquidity
Debt to equity
0.85
Current ratio
1.31
Quick ratio
1.04
Net debt/EBITDA
2.77
Margins
EBITDA margin
18.3%
Gross margin
33%
Net margin
9.2%
Operating margin
13.6%
Efficiency
Return on assets
6.4%
Return on equity
13.6%
Return on invested capital
16.4%
Return on capital employed
10.3%
Return on sales
13.6%
Dividend
Dividend yield
2.14%
DPS
$2.84
Payout ratio
37.4%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
1.41%
1 week
3.17%
1 month
5.77%
1 year
-4.24%
YTD
-3.6%
QTD
-3.6%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$9.25B
Gross profit
$3.05B
Operating income
$1.26B
Net income
$854M
Gross margin
33%
Net margin
9.2%
Quest Diagnostics's net margin has increased by 12% QoQ but it has decreased by 4.2% YoY
The net income has grown by 12% from the previous quarter but it has contracted by 10% YoY
DGX's operating income is up by 12% since the previous quarter but it is down by 12% year-on-year
The company's operating margin rose by 11% QoQ but it fell by 6% YoY

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
P/E
17.51
P/B
2.37
P/S
1.62
EV/EBIT
15.47
EV/EBITDA
11.46
EV/Sales
2.1
DGX's price to earnings (P/E) is 17% higher than its 5-year quarterly average of 14.8 but 10% lower than its last 4 quarters average of 19.1
DGX's EPS is up by 12% since the previous quarter but it is down by 6% year-on-year
Quest Diagnostics's equity has increased by 7% YoY
The stock's price to book (P/B) is 6% less than its 5-year quarterly average of 2.5 and 2.5% less than its last 4 quarters average of 2.4
The stock's price to sales (P/S) is 6% less than its 5-year quarterly average of 1.7
The revenue has contracted by 6% YoY

Efficiency

How efficient is Quest Diagnostics business performance
DGX's return on sales is up by 13% since the previous quarter
Quest Diagnostics's return on invested capital has decreased by 11% YoY but it has increased by 11% QoQ
DGX's ROE is down by 11% year-on-year but it is up by 10% since the previous quarter
DGX's return on assets is down by 11% year-on-year but it is up by 10% since the previous quarter

Dividends

What is DGX's dividend history
DPS
$2.84
Dividend yield
2.14%
Payout ratio
37.4%
Recent dividends

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 83% greater than the total liabilities
Quest Diagnostics's quick ratio has increased by 18% QoQ and by 7% YoY
The current ratio has increased by 17% QoQ and by 7% YoY
Quest Diagnostics's debt is 15% lower than its equity
Quest Diagnostics's debt has increased by 16% YoY and by 9% QoQ
The company's debt to equity rose by 12% QoQ and by 9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.